Fouad Namouni's Net Worth
$7.58 Million
Who is Fouad Namouni?
Fouad Namouni has an estimated net worth of $7.58 Million. This is based on reported shares across multiple companies, which include Blueprint Medicines Corp, Aprea Therapeutics, Inc., and Vor Biopharma Inc..
SEC CIK
Fouad Namouni's CIK is 0001815851
Past Insider Trading and Trends
2021 was Fouad Namouni's most active year for acquiring shares with 4 total transactions. Fouad Namouni's most active month to acquire stocks was the month of February. 2023 was Fouad Namouni's most active year for disposing of shares, totalling 3 transactions. Fouad Namouni's most active month to dispose stocks was the month of February. 2020 saw Fouad Namouni paying a total of $0.00 for 104,500 shares, this is the most they've acquired in one year. In 2024 Fouad Namouni cashed out on 4,377 shares for a total of $396,950.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Blueprint Medicines Corp (BPMC) Snapshot price: $86.43
PRESIDENT, R & D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.68% | -4.38K |
$90.69 | -$396,950.13 | 72.7K |
Mar 7
| |||
Form 4
| +24.16% | 15K |
—
|
—
| 77.08K |
Mar 1
| |||
Form 4
| -5.72% | -3.77K |
$48.06 | -$181,138.14 | 62.08K |
Oct 4
| |||
Form 4
| -2.87% | -1.95K |
$45.68 | -$88,976.88 | 65.85K |
Mar 6
| |||
Form 4
| +28.41% | 15K |
—
|
—
| 67.8K |
Mar 1
| |||
Form 4
| -6.18% | -3.48K |
$67.30 | -$234,002.10 | 52.8K |
Oct 4
| |||
Form 4
| -1.83% | -1.05K |
$56.19 | -$58,830.93 | 56.27K |
Mar 7
| |||
Form 4
| +35.44% | 15K |
—
|
—
| 57.32K |
Mar 1
| |||
Form 4
| -7.11% | -3.24K |
$98.18 | -$318,201.38 | 42.32K |
Oct 5
| |||
Form 4
| +40.19% | 13.06K |
—
|
—
| 45.56K |
Mar 1
| |||
Form 4
|
∞
| 32.5K |
—
|
—
| 32.5K |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.61K |
—
|
—
| 4.61K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vor Biopharma Inc. (VOR) Snapshot price: $0.9001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||